✦ LIBER ✦

Mutations of the PIK3CA gene in hereditary colorectal cancers

✍ Scribed by Michiko Miyaki; Takeru Iijima; Tatsuro Yamaguchi; Keiichi Takahashi; Hiroshi Matsumoto; Michiya Yasutome; Nobuaki Funata; Takeo Mori

Publisher: John Wiley and Sons
Year: 2007
Tongue: French
Weight: 110 KB
Volume: 121
Category: Article
ISSN: 0020-7136
DOI: 10.1002/ijc.22829

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Somatic mutations of the PIK3CA gene have recently been detected in various human cancers, including sporadic colorectal cancer. However, mutations of the PIK3CA gene in hereditary colorectal cancers have not been clarified. To elucidate the mutation status in familial adenomatous polyposis (FAP) and hereditary nonpolyposis colorectal cancer (HNPCC), which are the most common hereditary colorectal cancers, we investigated PIK3CA mutations in 163 colorectal tumors, including adenomas, intramucosal carcinomas and invasive carcinomas. For comparison, we also analyzed mutations of the same gene in 160 sporadic colorectal tumors at various histopathological stages. Analysis at exons 1, 7, 9 and 20 of the PIK3CA gene revealed somatic mutations in 21% (8 of 39) of FAP invasive carcinomas, 21% (7 of 34) of HNPCC invasive carcinomas, 15% (8 of 52) of sporadic invasive carcinomas, and 14% (7 of 50) of sporadic colorectal metastases in the liver. Mutations in FAP and HNPCC carcinomas predominantly occurred in the kinase domain (exon 20), while the majority of mutations in sporadic cases occurred in the helical domain (exon 9). Adenomas and intramucosal carcinomas from all patients exhibited no mutations (0 of 148). Our data suggest that PIK3CA mutations contribute to the invasion step from intramucosal carcinoma to invasive carcinoma in colorectal carcinogenesis in FAP and HNPCC patients at a similar extent to that seen in sporadic patients. © 2007 Wiley‐Liss, Inc.

📜 SIMILAR VOLUMES

PIK3CA mutation is predictive of poor su

PIK3CA mutation is predictive of poor survival in patients with colorectal cancer

✍ Shunsuke Kato; Satoru Iida; Tetsuro Higuchi; Toshiaki Ishikawa; Yoko Takagi; Mas 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 464 KB 👁 1 views

## Abstract The PI3K‐AKT pathway is activated in a variety of human cancers, resulting in disturbance of cell growth, proliferation and survival. Among the factors affecting the pathway, the __K‐Ras__ mutation and __PIK3CA__ mutation are the most common oncogenic alterations in colorectal cancer. W

Mutation analysis of PIK3CA and PIK3CB i

Mutation analysis of PIK3CA and PIK3CB in esophageal cancer and Barrett's esophagus

✍ Wayne A. Phillips; Sarah E. Russell; Marianne L. Ciavarella; David Y.H. Choong; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 81 KB 👁 1 views

## Abstract Mutation of __PIK3CA__, the gene coding for the p110α catalytic subunit of phosphoinositide 3‐kinase (PI3K), has been reported in a limited range of human tumors. We now report that __PIK3CA__ is also mutated in esophageal tumors. Single‐strand conformational polymorphism (SSCP) and den

Mutation of the hMSH2 gene in two famili

Mutation of the hMSH2 gene in two families with hereditary nonpolyposis colorectal cancer

✍ Hae Mung Jeon; Patrick M. Lynch; Linda Howard; Jaffer Ajani; Bernard Levin; Mars 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 554 KB

Communicated by Sauiu L.C. Woo We examined 18 unrelated individuals who have colorectal cancer or cancers associated with the HNPCC syndrome and have a family history of cancer for mutations in exon 13 of the hMSH2 gene. Two of the 18 individuals had the same previously unreported single-base delet

Detection of point mutations of the Axin

Detection of point mutations of the Axin1 gene in colorectal cancers

✍ Li-Hua Jin; Qiu-Jie Shao; Wen Luo; Zhi-Yun Ye; Qing Li; Sheng-Cai Lin 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 433 KB 👁 1 views

## Abstract Axin is a recently identified tumor suppressor that plays an important role in liver and colon cancers. To gain further insights into the structure and function of Axin in controlling cell growth, we analyzed 54 colorectal cancer tissues for mutations in AXIN1 gene. We employed PCR ampl

Phosphorylated AKT expression is associa

Phosphorylated AKT expression is associated with PIK3CA mutation, low stage, and favorable outcome in 717 colorectal cancers

✍ Yoshifumi Baba; Katsuhiko Nosho; Kaori Shima; Marika Hayashi; Jeffrey A. Meyerha 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 357 KB 👁 1 views

## Abstract ## BACKGROUND: AKT (AKT1, AKT2, and AKT3) was a downstream effector of phosphatidylinositide‐3‐kinase (PI3K) and played crucial roles in protein synthesis, cellular metabolism, survival, and proliferation. The PI3K/AKT pathway was commonly activated in human cancers and was recognized

K-ras and p53 mutations in hereditary no

K-ras and p53 mutations in hereditary non-polyposis colorectal cancers

✍ Lorena Losi; Maurizio Ponz de Leon; Josef Jiricny; Carmela Di Gregorio; Piero Be 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 57 KB 👁 2 views

Genetic instability related to defective DNA mismatch repair genes may be involved in the pathogenesis of carcinoma in Hereditary Non-Polyposis Colorectal Cancer (HN-PCC). To test that the targets of genetic instability could include critical transforming genes involved in colon tumor progression, w